The Research and Training Core provides professional and non-professional training and outreach programs to publicize the ADRC, improve clinical and research skills related to Alzheimer's disease (AD), and foster interest in AD and related disorders.
Three aims are carried forward from the original granting period to the current proposal. These include: 1) Establishment, provision, and refinement of professional educational programs on AD and related disorders. 2) Establishment, provision, and refinement of annual public educational programs on AD and related disorders. 3) Dissemination and evaluation of current training materials on AD and related disorders. To fulfill these aims, this core will continue to present annual CME programs, public forums, monthly seminars, and lectures on AD and related disorders. Collaborations with the Alzheimer's Association, the Northwest Geriatric Education Center, and other agencies and groups in the greater Seattle-Tacoma, as well as the Washington-Alaska-Montana-Idaho region, will continue so that we can disseminate the current state of clinical and research knowledge to interested parties outside and inside the Center. The core will also continue to disseminate a comprehensive training program on Managing and Understanding Behavior Problems in Alzheimer's Disease and Related Disorders and the quarterly newsletter, Dimensions. Both the training program and the newsletter have been evaluated in prior years and have received awards from professional associations. In addition, a fourth aim is to develop, implement, disseminate and evaluate specialized training programs to underserved populations. Specific attention will now be given to underserved populations that have not fully accessed the training programs thus far presented. Relevant to this geographic region, we will target Asians and Pacific Islanders, and Native Americans. Oral and written materials will be adapted to better suit the needs of these groups and special programs will be advertised and offered to educate and inform the public as well as health care professionals interested in working with these individuals.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
3P50AG005136-16S1
Application #
6216963
Study Section
Project Start
1999-08-15
Project End
2000-04-30
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
16
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Washington
Department
Type
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Crum, Jana; Wilson, Jeffrey; Sabbagh, Marwan (2018) Does taking statins affect the pathological burden in autopsy-confirmed Alzheimer's dementia? Alzheimers Res Ther 10:104
Turk, Katherine W; Flanagan, Margaret E; Josephson, Samuel et al. (2018) Psychosis in Spinocerebellar Ataxias: a Case Series and Study of Tyrosine Hydroxylase in Substantia Nigra. Cerebellum 17:143-151
Petyuk, Vladislav A; Chang, Rui; Ramirez-Restrepo, Manuel et al. (2018) The human brainome: network analysis identifies HSPA2 as a novel Alzheimer’s disease target. Brain 141:2721-2739
Bharadwaj, Rajnish; Cimino, Patrick J; Flanagan, Margaret E et al. (2018) Application of the condensed protocol for the NIA-AA guidelines for the neuropathological assessment of Alzheimer's disease in an academic clinical practice. Histopathology 72:433-440
Burke, Shanna L; Cadet, Tamara; Maddux, Marlaina (2018) Chronic Health Illnesses as Predictors of Mild Cognitive Impairment Among African American Older Adults. J Natl Med Assoc 110:314-325
Alosco, Michael L; Sugarman, Michael A; Besser, Lilah M et al. (2018) A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease Neuropathology. J Alzheimers Dis 63:1347-1360
Kamara, Dennis M; Gangishetti, Umesh; Gearing, Marla et al. (2018) Cerebral Amyloid Angiopathy: Similarity in African-Americans and Caucasians with Alzheimer's Disease. J Alzheimers Dis 62:1815-1826
Brent, Robert J (2018) Estimating the monetary benefits of medicare eligibility for reducing the symptoms of dementia. Appl Econ 50:6327-6340
Tulloch, Jessica; Leong, Lesley; Chen, Sunny et al. (2018) APOE DNA methylation is altered in Lewy body dementia. Alzheimers Dement 14:889-894
Deming, Yuetiva; Dumitrescu, Logan; Barnes, Lisa L et al. (2018) Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathol 136:857-872

Showing the most recent 10 out of 753 publications